Neuroectodermal Tumors, Primitive
-
Subject Areas on Research
- A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
- Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
- Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.
- Ellen, a 12-year-old girl, was given a diagnosis of a primitive neuroectodermal tumor.
- Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
- Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance).
- Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
- Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
- Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus.
- Glioneuronal tumors of the central nervous system.
- High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors.
- Intracranial Ewing sarcoma.
- Intraocular Medulloepitheliomas and Embryonal Tumors With Multilayered Rosettes of the Brain: Comparative Roles of LIN28A and C19MC.
- Intraocular Teratoid Medulloepithelioma Presenting With a Completely Rhabdomyosarcomatous Distant Metastasis.
- Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
- Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice.
- Patterns of care in adult medulloblastoma: results of an international online survey.
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
- Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
- Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
- Primary intracranial Ewing's sarcoma with unusual features.
- Radiomics Can Distinguish Pediatric Supratentorial Embryonal Tumors, High-Grade Gliomas, and Ependymomas.
- Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
- Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
- The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial.
- The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
- White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.